Bayer Aktiengesellschaft (BAYZF)
OTCMKTS · Delayed Price · Currency is USD
32.55
-0.65 (-1.96%)
Aug 25, 2025, 4:00 PM EDT
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
$605,506
Profits / Employee
-$44,822
Market Cap
32.74B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
Dec 31, 2023 | 96,931 | -991 | -1.01% |
Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
Dec 31, 2021 | 95,950 | -5 | -0.01% |
Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 68 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Bayer Aktiengesellschaft News
- 5 days ago - Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program - GlobeNewsWire
- 8 days ago - Bayer reaches settlement in PCB exposure lawsuits from Seattle-area school - Seeking Alpha
- 8 days ago - Bayer settles Sky Valley cases over chemical PCB - Reuters
- 11 days ago - Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market - Business Wire
- 11 days ago - LumenHaus Powers Bayer 04 Leverkusen as Official Premium Partner for 2025/26 Season - GlobeNewsWire
- 13 days ago - Why are Indoco Remedies shares up 2% today? Explained - Business Upturn
- 14 days ago - Bayer and Kumquat Biosciences partner to develop cancer treatment - Seeking Alpha
- 14 days ago - Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology - Business Wire